Delivery Order SPE2DB25D3108-SPE2DB25FPDUZ
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,906.47 for Zepbound 2.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $42,553.88 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management and diabetes treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,213.05 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. The contract was awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, and utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,928.55 to AmerisourceBergen Drug Corp for ZEPBOUND 2.5 MG/0.5 ML Pen 0.5ML, a GLP-1 receptor agonist medication used for weight management. The contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, was competitively awarded without set-aside designation and carries firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,575.48 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. The contract was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a competitively awarded, firm fixed-price transaction with no set-aside designation. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $9,725.21 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used in diabetes and weight management treatment. This firm fixed-price, competitively awarded delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,831.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a small-value transaction for the supply of this GLP-1 receptor agonist medication used in weight management and metabolic health treatment. The delivery order is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $11,086.64 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injectors (0.5 mL), a GLP-1 receptor agonist medication used for weight management. This firm fixed price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,089.68 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pens, a GLP-1 receptor agonist indicated for weight management. This firm fixed-price delivery order, which will be completed by August 12, 2025, represents a direct purchase under an existing contract vehicle and carries no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $25,048.41 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order, effective August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in...